Smiths News PLC (SNWS:LSE) delivered a robust FY2025 performance, reporting adjusted operating profit of £39.1 million—exceeding market expectations—and maintaining resilient cash generation with £36.1 million in free cash flow. CEO Jonathan Bunting and CFO Paul Baker highlighted the continued strength of the core news and magazine division, which underpins the group’s diversification strategy across four verticals: news and magazines, collectibles, recycling, and final mile logistics. Despite a modest 3.6% revenue decline, the company achieved 16% growth in its new verticals and a 17% uplift in collectibles revenue, driven by strong demand for Pokémon and Premier League trading cards. Operational efficiencies delivered £4.9 million in annualised savings, while cost and investment programs continue to enhance warehouse and transport management capabilities. Smiths News ended the year with a £3.3 million net cash position, supported by £6.9 million in one-off receipts, including £5.4 million recovered from the McColl’s administration. Shareholder returns remain a priority, with a proposed final dividend of 3.8p and a special dividend of 3p, bringing total FY2025 dividends to 8.55p and £38 million returned to shareholders over two years. Looking ahead, management expects sustained resilience in its core business, further expansion in high-margin verticals, and the completion of its £6 million investment programme by FY2027. With stable cash flow and a disciplined capital allocation policy, Smiths News remains well-positioned for continued profitability and value creation.

Montanaro European Smaller Companies Trust PLC (LSE:MTE) delivered an encouraging investor update reaffirming its disciplined quality growth investment strategy and commitment to long-term shareholder value. The Board expressed confidence in the company’s proven investment process and recent initiatives designed to enhance returns, including semiannual tender offers, an active share buyback programme to maintain a single-digit discount to NAV, and management fee reductions to strengthen cost efficiency and investor alignment. The Trust continues to focus on high-quality, profitable European small-cap companies with strong margins, recurring revenues, and exceptional management teams, identifying undervalued “hidden gems” with structural growth potential across diverse sectors. Despite recent headwinds for small-cap and growth investing, stock selection has consistently delivered positive results, supported by a robust, research-driven approach and low portfolio turnover. The presentation highlighted that European small caps are trading at historically attractive valuations relative to large caps, offering compelling opportunities for long-term investors. With a healthy order book, solid balance sheets, consistent EBITDA and margin growth, and gearing of around 6%, the portfolio remains well positioned to benefit as market sentiment improves. Backed by one of Europe’s most experienced specialist teams and a long track record of strong revenue growth and multi-bagger performance, the Trust remains focused on identifying tomorrow’s champions today. Overall, the update reinforced confidence in its disciplined investment philosophy, sustainable performance potential, and ongoing strategy to deliver superior growth and shareholder returns in the European smaller companies market.

HarbourVest Global Private Equity Limited (HVPE:LSE) delivered a strong semiannual investor update showcasing resilient company performance, solid NAV growth, and disciplined capital allocation across its diversified global portfolio. The fund reported total net assets of $4.2 billion, marking a 6.2% NAV per share increase in the half-year—driven by 5.6% portfolio growth and 0.6% buyback impact—and representing a 5.6x NAV increase since IPO with a 211% 10-year total shareholder return in sterling. HVPE’s diversified portfolio of over 1,000 private companies spans venture, growth equity, buyouts, private credit, and infrastructure, sustaining long-term NAV growth of 13.1% annually in USD and maintaining robust margins through a conservative valuation approach. Its $200 million share buyback program, launched in 2022, has enhanced NAV by more than 5%, while the newly introduced Separately Managed Account (SMA) structure, starting with a $125 million tranche in 2025, is designed to optimize liquidity, improve cash flow predictability, and reduce gearing. Backed by $115 million in cash and $629 million in undrawn facilities, HVPE remains well-capitalized to capture emerging private market opportunities amid renewed deal activity and stronger valuations in high-performing sectors such as technology and software (35% of NAV). Expanding exposure to the UK and India further underpins its global growth strategy. Management reaffirmed its focus on disciplined reinvestment, proactive capital return policies, and consistent outperformance versus public benchmarks, positioning HVPE for continued NAV expansion, robust EBITDA generation, and sustainable long-term shareholder value creation.

BlackRock American Income Trust PLC (BRAI:LSE) showcased its enhanced systematic investment strategy in the latest investor presentation, led by co-portfolio manager Muzo Kayacan. Following a management transition earlier in 2025, the fund is now managed by BlackRock’s Systematic Active Equity team, a $378 billion global platform with over 40 years of experience in data-driven US equity investing. The Trust’s strategy combines AI, machine learning, and text analysis to convert vast unstructured data—such as earnings transcripts, broker research, and social media signals—into structured insights that inform stock selection. Its diversified portfolio of 150–250 US value stocks is benchmarked against the Russell 1000 Value Index, with the objective of delivering consistent, moderate outperformance and a target dividend yield of around 6% per annum (1.5% quarterly). BlackRock’s scale and cross-trading efficiencies enable low transaction costs and disciplined risk control, while its use of alternative datasets and ESG-integrated metrics provides forward-looking insights into company fundamentals. Since assuming management in May 2025, BRNA has reported steady performance in line with expectations, positioning the Trust as a high-conviction, income-focused US equity vehicle that leverages cutting-edge systematic research, AI analytics, and diversification to enhance long-term investor returns.

Croma Security Solutions Group PLC (CSSG:AIM) delivered a robust FY25 performance, underscoring the success of its acquisition-led growth strategy in the UK’s fragmented locksmith and security market. Revenue rose 10% to £9.63 million, with EBITDA up 10% to £1.17 million and operating margins stable at 12.1%. The group maintained a strong balance sheet with £4.3 million in cash, no borrowings, and a proposed final dividend of 2.4p per share. FY26 trading has started well, supported by new store openings, a healthy acquisition pipeline, and £1.2 million in deferred Vigilant sale payments due by June 2026. Croma continues to reinvest proceeds from asset disposals into expanding its nationwide Security Centre network, targeting 3–5 acquisitions per annum at returns of 15% or higher. Its integrated model—combining locksmithing, electronic security, and industrial doors—provides recurring revenues from long-term institutional clients and opportunities for cross-selling. The company’s bespoke software platform delivers operational efficiencies, while selective property ownership offers additional income and financial flexibility. Management emphasized disciplined acquisition criteria, strong like-for-like growth (5%), and enhanced shareholder value through consolidation of independent locksmiths under the Croma brand. 

IXICO PLC (IXI:LSE), a UK-based neuroimaging and AI-driven clinical research organization, showcased robust performance and strategic progress across its precision neuroscience portfolio, underscoring its transformation into a leading imaging CRO (“iCRO”) focused on Alzheimer’s, Parkinson’s, Huntington’s, and other neurodegenerative diseases. Delivering 13% revenue growth to £6.5 million and maintaining a £13.8 million order book, IXICO continues to advance its Innovate, Lead, Scale strategy through proprietary AI analytics, deep-learning imaging segmentation, and multimodal biomarker integration that enhance trial precision and accelerate CNS drug development. Recent investor updates highlighted collaborations with industry leaders such as Lundbeck and thought leaders like Professor Mike Weiner (UCSF), reinforcing IXICO’s pivotal role in advancing translational biomarkers, early disease detection, and digital health integration. The company’s scalable platform—combining MRI, PET, and blood biomarker analytics—supports over 80% of active neurodegenerative clinical trials, driving operational efficiency, EBITDA margin expansion, and sustainable top-line growth. With accelerating demand for AI-enabled imaging solutions, emerging opportunities in prevention trials and GLP-1 therapies, and expanding U.S. and global partnerships, IXICO is well-positioned to deliver continued double-digit revenue growth, profitability recovery, and long-term shareholder value as a market leader in precision neuroscience and data-driven clinical innovation.

Petra Diamonds Limited (PDL:LSE) presented its Q1 FY2026 operating and financial update, highlighting continued operational progress, improved product mix, and momentum toward completing its refinancing before year-end to strengthen the balance sheet and unlock long-term value. The group emphasized transformation into a leaner, more efficient business centered on its two world-class assets—Cullinan and Finsch Mines—positioned to deliver sustainable value. Safety performance remained strong, with 8.5 years fatality-free and an LTIFR improvement to 0.27, underscoring operational discipline amid structural shifts to new shift configurations. Cullinan saw a 6% throughput reduction due to the shift transition but achieved a significantly improved product mix from higher-quality ore at the CC1 East and eastern S-Cut blocks, boosting tender results. Finsch delivered 37% higher carat production year-on-year as the two-shift system stabilized. Diamond sales reached $52m from 470k carats, with average prices up 53% quarter-on-quarter, driven by mix quality despite subdued global demand and U.S. tariff uncertainty. Net debt rose to $287m, reflecting timing of tenders and FX impacts, while cost discipline continued, with total cash costs falling year-on-year. Management reiterated FY2026 guidance and maintained pricing assumptions, expecting product mix improvements and cost efficiencies to offset macro headwinds. The refinancing process, including a rights issue due by 27 November, is on track and expected to secure Petra’s financial flexibility. Post-refinancing, management will focus on delivering capital projects, sustaining operational stability, and executing growth plans through FY2028. Petra remains confident that its simplified structure, disciplined capital allocation, and operational resilience position it well to capture upside from any recovery in natural diamond demand amid market stabilization.

Custodian Property Income REIT plc (LSE: CREI) delivered a strong investor update highlighting robust portfolio performance, disciplined growth, and an attractive value opportunity in UK commercial real estate. Managing Director Richard Shepherd-Cross emphasized CREI’s focus on generating high, stable dividends through a well-diversified portfolio of regional UK properties, offering investors a fully covered 7.5% dividend yield and resilient earnings supported by a 14% reversionary potential and consistent rental growth across industrial, retail, and office sectors. With a solid balance sheet, reduced loan-to-value ratio of 26.9%, and active asset management, CREI continues to strengthen income visibility and deliver sustainable dividend cover. The company’s growth strategy remains focused on smaller regional assets that offer higher yields, reduced competition, and ESG-led value creation, exemplified by the tax-efficient Merlin Properties acquisition. Despite broader market uncertainty, CREI benefits from resilient fundamentals—limited supply, rising rents, and increasing private equity and retail investor interest in discounted listed real estate. Forecasts suggest total annual returns of around 8% over the next five years, driven by rental growth rather than yield compression. Supported by disciplined capital allocation, targeted share buybacks, and a diversified tenant base with 85% rated lower-than-average risk, CREI offers investors a compelling combination of income security, portfolio stability, and long-term growth potential. Positioned as a leading income-focused UK REIT, Custodian Property Income continues to demonstrate operational resilience, prudent financial management, and strong investor alignment amid a recovering property market.

Avacta Group PLC (AVCT:AIM) delivered an investor update highlighting progress on its precision, FAP-activated peptide drug conjugate (PDC) platform and near-term catalysts. Lead program AVA6000 (ferri-doxorubicin) continues to show a favorable safety profile with no cardiac toxicity observed to date, limited severe neutropenia, and ~100:1 tumor-to-plasma exposure, alongside encouraging activity in salivary gland cancer and sarcoma. Management unveiled a dual-payload PDC that releases two synergistic drugs in the tumor microenvironment (e.g., exotecan with MMAE or DDR inhibitors such as ATR/PARP), offering tunable kinetics, strong tumor penetration, and manufacturing homogeneity. Compared with antibody drug conjugates, the strategy targets FAP (expressed across the majority of solid tumors) for specific extracellular release, supporting a broad addressable market and reduced off-target effects. Key milestones include selection of a dual-payload clinical candidate in H2 next year, initiation of the FAP-exotecan Phase 1 trial with first patient targeted for Q1 2026, late-2025 expansion-cohort data in salivary gland cancer, and mid-2026 breast cancer data. The company also noted ongoing partnership discussions and a strengthened financial position, with the recent fundraise extending cash runway into H2 2026 to support trial start-up and growth strategy execution. Overall, the presentation underscores company performance against roadmap milestones and a clear path to value creation for investors through pipeline advancement, disciplined capital allocation, and potential licensing.

RIT Capital Partners Plc’s (LSE:RCP) latest investor update showcases strong financial results, strategic diversification, and sustained long-term growth. The FTSE 250-listed investment trust, founded by Lord Rothschild and managing over £4 billion in assets, continues to outperform global benchmarks with NAV per share total return of 10% year-to-date and 10.6% over 12 months. Growth has been driven by a balanced portfolio across quoted equities, private investments, and uncorrelated strategies, delivering both capital appreciation and stability. Private investments remain a key driver, generating a 9% return in H1 2025 and significant realizations from Zappo Bank (2.3x), Scale AI (1.7x), and Webull (2x), supported by partnerships with elite managers such as Thrive Capital, Founders Fund, and Green Oaks, giving shareholders access to exclusive opportunities in leading firms including SpaceX, Stripe, and Epic Systems. In public markets, RIT’s strategy focuses on quality growth and structural themes - notably in Japan, biotech, and global technology - while its absolute return, credit, and gold allocations enhance portfolio resilience and deliver steady, uncorrelated returns. Amid ongoing market volatility and shifting geopolitical dynamics, RIT’s flexible, diversified investment approach and global network continue to position it for sustainable performance. With a proven record of 102% NAV growth over the past decade and lower volatility than equity markets, RIT Capital Partners stands out as a core long-term investment vehicle offering compounded returns, portfolio resilience, and exposure to exclusive private and public market opportunities.